Challenges in the codevelopment of companion diagnostics

Author:

Moore Mathew W1,Babu Deepti2,Cotter Philip D3

Affiliation:

1. ResearchDx, 13766 Alton Parkway, Suite 147, Irvine, CA 92618, USA

2. University of Alberta, Department of Medical Genetics, Edmonton, Alberta, Canada

3. ResearchDx, 13766 Alton Parkway, Suite 147, Irvine, CA 92618, USA.

Abstract

Therapeutics harnessing the power of personalized medicine have the potential to revolutionize healthcare. Companion diagnostics are critical to this goal and are increasingly relied upon to ensure the effective, safe development and use of a personalized therapeutic. Companion diagnostics are the focus of several recent regulatory guidance documents; the drug–diagnostic codevelopment process has become increasingly relevant and necessary. Despite this, the promise of companion diagnostics has not been fully realized and there are multiple difficulties that still need resolution. The path to codevelop a successful companion diagnostic with its complementary drug is complex, fragmented and fraught with several challenges. In this article, we discuss the logistic, strategic business, regulatory and financial challenges involved in drug-companion diagnostic codevelopment.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Molecular Medicine,General Medicine

Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Fast-tracking drug development with biomarkers and companion diagnostics;Journal of Cancer Metastasis and Treatment;2024-01-18

2. Zukunftspotenziale der Labormedizin;Nutzen der Labormedizin in der Schweiz;2023

3. Pricing and market entry decisions in personalized medicine;International Journal of Production Economics;2022-11

4. Protein array-based companion diagnostics in precision medicine;Expert Review of Molecular Diagnostics;2020-12-01

5. Pharmacogenomic phase transition from personalized medicine to patient-centric customized delivery;The Pharmacogenomics Journal;2019-12-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3